Resolution of intracardiac and pulmonary thrombi without anticoagulation in a patient with Behcet's disease: a case report

被引:0
作者
Samrah, S. M. [1 ]
Saadeh, S. S. [2 ]
Alawneh, K. M. [1 ]
机构
[1] Jordan Univ Sci & Technol, Fac Med, Dept Internal Med, Irbid, Jordan
[2] King Abdullah Univ Hosp, Dept Internal Med, Irbid 22110, Jordan
关键词
Behcet's disease; cardiovascular involvement; thrombotic manifestations; intraventricular thrombus; LESIONS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intracardiac and pulmonary thrombi are rare but serious manifestations of Behcet's disease, the treatment of such cases is a challenge to the treating physician and use of anticoagulants can hold a great risk to some patients. We report a patient who was found to have multiple right intraventricular and bilateral pulmonary artery thrombi and was clinically diagnosed with Behcet's disease. Early in the course of his treatment, the patient developed massive haemoptysis which precluded the further use of anticoagulants. The patient was treated with immunosuppressants alone and had complete resolution of his symptoms and documented resolution of the thrombi. In a review of the literature, only 3 out of around 50 patients reported to have intracardiac thrombi complicating Behcet's disease were treated without anticoagulants (1, 2) even though there is no clear evidence to support the benefit of anticoagulation to treat arterial or thrombotic lesions (3). We conclude that intracardiac thrombi in patients with Behcet's disease may resolve with immunosuppressants without anticoagulation, which is especially important in patients with contraindication to anticoagulation.
引用
收藏
页码:S90 / S92
页数:3
相关论文
共 12 条
  • [1] Behcet's disease: Successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis
    Adler, Sabine
    Baumgartner, Iris
    Villiger, Peter M.
    [J]. ARTHRITIS CARE & RESEARCH, 2012, 64 (04) : 607 - 611
  • [2] [Anonymous], LANCET
  • [3] Anti-TNF Agents for Behcet's Disease: Analysis of Published Data on 369 Patients
    Arida, Aikaterini
    Fragiadaki, Kalliopi
    Giavri, Eirini
    Sfikakis, Petros P.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (01) : 61 - 70
  • [4] Pulmonary manifestations of Behcet's disease
    Erkan, F
    Gül, A
    Tasali, E
    [J]. THORAX, 2001, 56 (07) : 572 - 578
  • [5] Spectrum of Cardiac Lesions in Behcet Disease A Series of 52 Patients and Review of the Literature
    Geri, Guillaume
    Wechsler, Bertrand
    Du Le Thi Huong
    Isnard, Richard
    Piette, Jean-Charles
    Amoura, Zahir
    Resche-Rigon, Mathieu
    Cacoub, Patrice
    Saadoun, David
    [J]. MEDICINE, 2012, 91 (01) : 25 - 34
  • [6] Azathioprine in Behcet's syndrome - Effects on long-term prognosis
    Hamuryudan, V
    Ozyazgan, Y
    Hizli, N
    Mat, C
    Yurdakul, S
    Tuzun, Y
    Senocak, M
    Yazici, H
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (04): : 769 - 774
  • [7] EULAR recommendations for the management of Behcet disease
    Hatemi, G.
    Silman, A.
    Bang, D.
    Bodaghi, B.
    Chamberlain, A. M.
    Gul, A.
    Houman, M. H.
    Kotter, I.
    Olivieri, I.
    Salvarani, C.
    Sfikakis, P. P.
    Siva, A.
    Stanford, M. R.
    Stuebiger, N.
    Yurdakul, S.
    Yazici, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) : 1656 - 1662
  • [8] Huong DL, 1997, BRIT J RHEUMATOL, V36, P130
  • [9] Intracardiac thrombus in Behcet's disease - A systematic review
    Mogulkoc, N
    Burgess, MI
    Bishop, PW
    [J]. CHEST, 2000, 118 (02) : 479 - 487
  • [10] Owlia M, 2012, ISRN PHARM, DOI [10.5402/2012/760484, DOI 10.5402/2012/760484]